About
Antibody Discovery Arrays, ADCs
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyBiotech
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
374
By Phase
EARLY_PHASE1: 1PHASE1/PHASE2: 2PHASE1: 2
By Status
RECRUITING: 5
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06400485Lead Sponsor
AMT-676 in Patients With Advanced Solid Tumors
EARLY_PHASE1Recruiting
24 participants
Started: Jun 18, 2024 · Completed: Feb 14, 2026
NCT06782334Lead Sponsor
AMT-116 in Patients with Solid Tumors
PHASE1/PHASE2Recruiting
144 participants
Started: May 7, 2024 · Completed: Dec 30, 2026
NCT06209580Lead Sponsor
AMT-253 in Patients With Advanced Solid Tumours
PHASE1/PHASE2Recruiting
96 participants
Started: Jan 31, 2024 · Completed: Dec 31, 2026
NCT05725291Lead Sponsor
AMT-116 in Patients With Advanced Solid Tumors
PHASE1Recruiting
80 participants
Started: Jul 25, 2023 · Completed: Dec 30, 2026
NCT05498597Lead Sponsor
AMT-151 in Patients With Selected Advanced Solid Tumours
PHASE1Recruiting
30 participants
Started: Jan 25, 2023 · Completed: Oct 30, 2024
Locations (1)
Headquarters
Redwood City, CA, United States
Map
Loading map...